Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +25.00%·Rev n/aQ2 22EPS -100.00%·Rev n/aQ1 22EPS +33.33%·Rev n/aQ4 21EPS -100.00%*·Rev n/a⚠ consensus missing

Lineage Cell Therapeutics, Inc. LCTX

Ioana Hone — Investor Relations or Communications

Brian Culley — Chief Executive Officer

+6.4%1d on move date+0.9% vs SPY3d+8.8%5d+4.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LCTX calls or request research access.

More LCTX calls Browse calls Request research access